Boston Partners Rx Sight, Inc. Transaction History

Boston Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$16.37 - $28.9 $107,223 - $189,295	-6,550 Reduced 24.27%	20,436 $588,000
Q1 2023 May 09, 2023	BUY	$12.58 - $16.68 $33,576 - $44,518	2,669 Added 10.98%	26,986 $450,000
Q4 2022 Feb 07, 2023	BUY	$9.93 - $14.2 $27,754 - $39,689	2,795 Added 12.99%	24,317 $308,000
Q3 2022 Nov 09, 2022	BUY	$11.19 - $15.85 $31,824 - $45,077	2,844 Added 15.23%	21,522 $258,000
Q2 2022 Aug 10, 2022	BUY	$10.61 - $16.66 $37,060 - $58,193	3,493 Added 23.0%	18,678 $263,000
Q4 2021 Feb 04, 2022	BUY	$9.52 - $13.81 $144,561 - $209,704	15,185 New	15,185 $171,000

225

32.3M

394K

32K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.3B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.